Capricor Therapeutics Ownership 2024 | Who Owns Capricor Therapeutics Now?
Institutional Ownership
20.50%
Insider Ownership
23.38%
Retail Ownership
56.13%
Institutional Holders
68.00
Capricor Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BLACKROCK INC. | 5.19% | 0.00% | 1,628,550 | 1,246,815 | 326.62% | 7,768,183 | Jun 30, 2024 |
| VANGUARD GROUP INC | 4.94% | 0.00% | 1,548,941 | 183,038 | 13.40% | 7,388,449 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.05% | 0.00% | 641,573 | 313,096 | 95.32% | 3,060,801 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 1.53% | 0.00% | 479,510 | 186,469 | 63.63% | 2,287,263 | Jun 30, 2024 |
| STATE STREET CORP | 1.28% | 0.00% | 401,022 | 284,298 | 243.56% | 1,912,875,000 | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | 0.97% | 0.02% | 305,700 | 305,700 | 100.00% | 1,458,189 | Jun 30, 2024 |
| ADVISOR GROUP HOLDINGS, INC. | 0.52% | 0.00% | 162,300 | 4,100 | 2.59% | 774,171 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.44% | 0.00% | 137,500 | 84,350 | 158.70% | 655,875 | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | 0.42% | 0.01% | 130,500 | 130,500 | 100.00% | 622,485 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.41% | 0.00% | 129,613 | 9,299 | 7.73% | 618,254,000 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 0.28% | 0.00% | 89,314 | 89,314 | 100.00% | 426,028 | Jun 30, 2024 |
| MAN GROUP PLC | 0.27% | 0.00% | 84,654 | 11,757 | 16.13% | 403,800 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.26% | 0.00% | 82,696 | -130,473 | -61.21% | 394,460 | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | 0.25% | 0.00% | 79,782 | 9,040 | 12.78% | 380,560 | Jun 30, 2024 |
| MORGAN STANLEY | 0.25% | - | 79,195 | -32,402 | -29.03% | 377,761 | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.23% | 0.00% | 73,468 | 59,989 | 445.06% | 350,442 | Jun 30, 2024 |
| OPPENHEIMER & CO INC | 0.17% | 0.00% | 54,646 | 54,646 | 100.00% | 260,661 | Jun 30, 2024 |
| JUMP FINANCIAL, LLC | 0.17% | 0.01% | 52,100 | -3,813 | -6.82% | 248,517 | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | 0.14% | 0.00% | 44,946 | 12,384 | 38.03% | 214,392 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 0.11% | - | 34,320 | 34,320 | 100.00% | 163,706 | Jun 30, 2024 |
Capricor Therapeutics's largest institutional shareholder is BLACKROCK INC., holding 5.19% of the company's total share outstanding, currently valued at $7.77M. The top 10 institutional shareholders own together 17.75% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| CAPTION MANAGEMENT, LLC | 0.97% | 0.02% | 305,700 | 305,700 | 100.00% | 1,458,189 | Jun 30, 2024 |
| OCCUDO QUANTITATIVE STRATEGIES LP | 0.08% | 0.02% | 25,151 | -906 | -3.48% | 119,970 | Jun 30, 2024 |
| ALPINE GLOBAL MANAGEMENT, LLC | 0.08% | 0.02% | 24,168 | 24,168 | 100.00% | 115,281 | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 0.07% | 0.02% | 20,400 | 20,400 | 100.00% | 97,308 | Jun 30, 2024 |
| ACTIVEST WEALTH MANAGEMENT | 0.03% | 0.02% | 10,000 | 10,000 | 100.00% | 47,700 | Jun 30, 2024 |
| COASTAL BRIDGE ADVISORS, LLC | 0.03% | 0.01% | 10,894 | - | - | 51,964 | Jun 30, 2024 |
| MAIN STREET FINANCIAL SOLUTIONS, LLC | 0.09% | 0.01% | 27,500 | 7,500 | 37.50% | 131,175 | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | 0.42% | 0.01% | 130,500 | 130,500 | 100.00% | 622,485 | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | 0.09% | 0.01% | 27,330 | 27,330 | 100.00% | 130,000 | Jun 30, 2024 |
| JUMP FINANCIAL, LLC | 0.17% | 0.01% | 52,100 | -3,813 | -6.82% | 248,517 | Jun 30, 2024 |
| OPPENHEIMER & CO INC | 0.17% | 0.00% | 54,646 | 54,646 | 100.00% | 260,661 | Jun 30, 2024 |
| HOUSEHOLDER GROUP ESTATE & RETIREMENT SPECIALIST, LLC | 0.00% | 0.00% | 1,500 | - | - | 7,000 | Jun 30, 2024 |
| ADVISOR GROUP HOLDINGS, INC. | 0.52% | 0.00% | 162,300 | 4,100 | 2.59% | 774,171 | Jun 30, 2024 |
| ENGINEERS GATE MANAGER LP | 0.04% | 0.00% | 13,419 | 13,419 | 100.00% | 64,009 | Jun 30, 2024 |
| TREXQUANT INVESTMENT LP | 0.06% | 0.00% | 18,879 | 18,879 | 100.00% | 90,053 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.44% | 0.00% | 137,500 | 84,350 | 158.70% | 655,875 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 1.53% | 0.00% | 479,510 | 186,469 | 63.63% | 2,287,263 | Jun 30, 2024 |
| MAN GROUP PLC | 0.27% | 0.00% | 84,654 | 11,757 | 16.13% | 403,800 | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 0.03% | 0.00% | 9,524 | 4,691 | 97.06% | 45,429 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 0.28% | 0.00% | 89,314 | 89,314 | 100.00% | 426,028 | Jun 30, 2024 |
The largest Capricor Therapeutics shareholder by % of total assets is CAPTION MANAGEMENT, LLC. The company owns 305.70K shares of Capricor Therapeutics (CAPR), representing 0.02% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BLACKROCK INC. | 5.19% | 0.00% | 1,628,550 | 1,246,815 | 326.62% | 7,768,183 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.05% | 0.00% | 641,573 | 313,096 | 95.32% | 3,060,801 | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | 0.97% | 0.02% | 305,700 | 305,700 | 100.00% | 1,458,189 | Jun 30, 2024 |
| STATE STREET CORP | 1.28% | 0.00% | 401,022 | 284,298 | 243.56% | 1,912,875,000 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 1.53% | 0.00% | 479,510 | 186,469 | 63.63% | 2,287,263 | Jun 30, 2024 |
| VANGUARD GROUP INC | 4.94% | 0.00% | 1,548,941 | 183,038 | 13.40% | 7,388,449 | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | 0.42% | 0.01% | 130,500 | 130,500 | 100.00% | 622,485 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 0.28% | 0.00% | 89,314 | 89,314 | 100.00% | 426,028 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.44% | 0.00% | 137,500 | 84,350 | 158.70% | 655,875 | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.23% | 0.00% | 73,468 | 59,989 | 445.06% | 350,442 | Jun 30, 2024 |
| OPPENHEIMER & CO INC | 0.17% | 0.00% | 54,646 | 54,646 | 100.00% | 260,661 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 0.11% | - | 34,320 | 34,320 | 100.00% | 163,706 | Jun 30, 2024 |
| RHUMBLINE ADVISERS | 0.10% | 0.00% | 30,886 | 30,886 | 100.00% | 147,318 | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | 0.09% | 0.01% | 27,330 | 27,330 | 100.00% | 130,000 | Jun 30, 2024 |
| ALPINE GLOBAL MANAGEMENT, LLC | 0.08% | 0.02% | 24,168 | 24,168 | 100.00% | 115,281 | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | 0.07% | 0.00% | 22,695 | 22,695 | 100.00% | 108,255 | Jun 30, 2024 |
| NEW YORK STATE COMMON RETIREMENT FUND | 0.07% | 0.00% | 21,600 | 21,600 | 100.00% | 103,000 | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 0.07% | 0.02% | 20,400 | 20,400 | 100.00% | 97,308 | Jun 30, 2024 |
| TREXQUANT INVESTMENT LP | 0.06% | 0.00% | 18,879 | 18,879 | 100.00% | 90,053 | Jun 30, 2024 |
| BARCLAYS PLC | 0.06% | - | 17,572 | 17,572 | 100.00% | 85,000 | Jun 30, 2024 |
As of Jun 30 2024, Capricor Therapeutics's largest institutional buyer is BLACKROCK INC.. The company purchased 1.25M stocks of CAPR, valued at $7.77M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| GOLDMAN SACHS GROUP INC | 0.26% | 0.00% | 82,696 | -130,473 | -61.21% | 394,460 | Jun 30, 2024 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | - | - | - | -101,542 | -100.00% | - | Jun 30, 2024 |
| HRT FINANCIAL LP | - | - | - | -82,557 | -100.00% | - | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 0.03% | - | 10,818 | -80,265 | -88.12% | 51,602 | Jun 30, 2024 |
| WELLINGTON MANAGEMENT GROUP LLP | - | - | - | -79,759 | -100.00% | - | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.05% | 0.00% | 14,433 | -54,970 | -79.20% | 68,845 | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -54,268 | -100.00% | - | Jun 30, 2024 |
| WALLEYE CAPITAL LLC | - | - | - | -47,646 | -100.00% | - | Jun 30, 2024 |
| MORGAN STANLEY | 0.25% | - | 79,195 | -32,402 | -29.03% | 377,761 | Jun 30, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | - | - | - | -24,570 | -100.00% | - | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | - | - | - | -23,678 | -100.00% | - | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | - | - | - | -19,537 | -100.00% | - | Jun 30, 2024 |
| BREVAN HOWARD CAPITAL MANAGEMENT LP | - | - | - | -19,468 | -100.00% | - | Jun 30, 2024 |
| OMERS ADMINISTRATION CORP | - | - | - | -18,000 | -100.00% | - | Jun 30, 2024 |
| HIGHTOWER ADVISORS, LLC | 0.03% | - | 9,000 | -15,000 | -62.50% | 2,700 | Jun 30, 2024 |
| LPL FINANCIAL LLC | 0.10% | 0.00% | 31,988 | -14,350 | -30.97% | 152,583 | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | - | - | - | -12,994 | -100.00% | - | Jun 30, 2024 |
| WOODLINE PARTNERS LP | - | - | - | -12,461 | -100.00% | - | Jun 30, 2024 |
| JEFFERIES FINANCIAL GROUP INC. | - | - | - | -10,600 | -100.00% | - | Jun 30, 2024 |
| PRUDENTIAL FINANCIAL INC | - | - | - | -10,000 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Capricor Therapeutics's biggest institutional seller is GOLDMAN SACHS GROUP INC. The company sold -0.13M shares of CAPR, valued at $394.46K.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| CAPTION MANAGEMENT, LLC | 0.97% | 0.02% | 305,700 | 305,700 | 100.00% | 1,458,189 | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | 0.42% | 0.01% | 130,500 | 130,500 | 100.00% | 622,485 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 0.28% | 0.00% | 89,314 | 89,314 | 100.00% | 426,028 | Jun 30, 2024 |
| OPPENHEIMER & CO INC | 0.17% | 0.00% | 54,646 | 54,646 | 100.00% | 260,661 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 0.11% | - | 34,320 | 34,320 | 100.00% | 163,706 | Jun 30, 2024 |
| RHUMBLINE ADVISERS | 0.10% | 0.00% | 30,886 | 30,886 | 100.00% | 147,318 | Jun 30, 2024 |
| ALPINE GLOBAL MANAGEMENT, LLC | 0.08% | 0.02% | 24,168 | 24,168 | 100.00% | 115,281 | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | 0.07% | 0.00% | 22,695 | 22,695 | 100.00% | 108,255 | Jun 30, 2024 |
| NEW YORK STATE COMMON RETIREMENT FUND | 0.07% | 0.00% | 21,600 | 21,600 | 100.00% | 103,000 | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 0.07% | 0.02% | 20,400 | 20,400 | 100.00% | 97,308 | Jun 30, 2024 |
| TREXQUANT INVESTMENT LP | 0.06% | 0.00% | 18,879 | 18,879 | 100.00% | 90,053 | Jun 30, 2024 |
| BARCLAYS PLC | 0.06% | - | 17,572 | 17,572 | 100.00% | 85,000 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.04% | 0.00% | 13,656 | 13,656 | 100.00% | 65,276 | Jun 30, 2024 |
| ENGINEERS GATE MANAGER LP | 0.04% | 0.00% | 13,419 | 13,419 | 100.00% | 64,009 | Jun 30, 2024 |
| INVESCO LTD. | 0.04% | - | 12,134 | 12,134 | 100.00% | 57,879 | Jun 30, 2024 |
| ACTIVEST WEALTH MANAGEMENT | 0.03% | 0.02% | 10,000 | 10,000 | 100.00% | 47,700 | Jun 30, 2024 |
| LEGAL & GENERAL GROUP PLC | 0.01% | - | 2,725 | 2,725 | 100.00% | 12,998 | Jun 30, 2024 |
| AMERITAS INVESTMENT PARTNERS, INC. | 0.01% | 0.00% | 2,487 | 2,487 | 100.00% | 11,863 | Jun 30, 2024 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 0.01% | - | 1,839 | 1,839 | 100.00% | 8,772 | Jun 30, 2024 |
| AMALGAMATED BANK | 0.00% | - | 878 | 878 | 100.00% | 4,000 | Jun 30, 2024 |
| SIGNATUREFD, LLC | 0.00% | - | 393 | 393 | 100.00% | 1,875 | Jun 30, 2024 |
Capricor Therapeutics's largest new institutional shareholder by number of shares is CAPTION MANAGEMENT, LLC, purchased 305.70K shares, valued at $1.46M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | - | - | - | -101,542 | -100.00% | - | Jun 30, 2024 |
| HRT FINANCIAL LP | - | - | - | -82,557 | -100.00% | - | Jun 30, 2024 |
| WELLINGTON MANAGEMENT GROUP LLP | - | - | - | -79,759 | -100.00% | - | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -54,268 | -100.00% | - | Jun 30, 2024 |
| WALLEYE CAPITAL LLC | - | - | - | -47,646 | -100.00% | - | Jun 30, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | - | - | - | -24,570 | -100.00% | - | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | - | - | - | -23,678 | -100.00% | - | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | - | - | - | -19,537 | -100.00% | - | Jun 30, 2024 |
| BREVAN HOWARD CAPITAL MANAGEMENT LP | - | - | - | -19,468 | -100.00% | - | Jun 30, 2024 |
| OMERS ADMINISTRATION CORP | - | - | - | -18,000 | -100.00% | - | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | - | - | - | -12,994 | -100.00% | - | Jun 30, 2024 |
| WOODLINE PARTNERS LP | - | - | - | -12,461 | -100.00% | - | Jun 30, 2024 |
| JEFFERIES FINANCIAL GROUP INC. | - | - | - | -10,600 | -100.00% | - | Jun 30, 2024 |
| PRUDENTIAL FINANCIAL INC | - | - | - | -10,000 | -100.00% | - | Jun 30, 2024 |
| HIGHTOWER ADVISORS, LLC | - | - | - | -5,000 | -100.00% | - | Jun 30, 2024 |
| LAZARD ASSET MANAGEMENT LLC | - | - | - | -2,693 | -100.00% | - | Jun 30, 2024 |
| MACQUARIE GROUP LTD | - | - | - | -941 | -100.00% | - | Jun 30, 2024 |
| YHB INVESTMENT ADVISORS, INC. | - | - | - | -150 | -100.00% | - | Jun 30, 2024 |
| FEDERATED HERMES, INC. | - | - | - | -68 | -100.00% | - | Jun 30, 2024 |
| FMR LLC | - | - | - | -1 | -100.00% | - | Jun 30, 2024 |
Capricor Therapeutics's largest sold out institutional shareholder by shares sold is ARROWSTREET CAPITAL, LIMITED PARTNERSHIP, sold -0.10M shares, valued at -, as of undefined.
Capricor Therapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| VANGUARD VALLEY FORGE FUNDS | 0.03% | 16,000 | - | - | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 1,308,425 | -167,696 | -11.36% | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 293,379 | 51,694 | 21.39% | Feb 29, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 17,890 | -1,341 | -6.97% | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 13,479 | - | - | Jan 31, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 33,601 | - | - | Jan 31, 2024 |
| NORTHERN FUNDS | 0.00% | 22,220 | - | - | Mar 28, 2024 |
| THRIVENT SERIES FUND INC | 0.00% | 15,001 | - | - | Mar 28, 2024 |
| THRIVENT MUTUAL FUNDS | 0.00% | 6,775 | - | - | Mar 28, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 700 | - | - | Mar 31, 2024 |
| Dimensional ETF Trust | 0.00% | 18,885 | - | - | Jan 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 27,028 | - | - | Jan 31, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 2,254 | - | - | Feb 29, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 2,776 | - | - | Jan 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 3,595 | -348 | -8.83% | Mar 31, 2024 |
| iSHARES TRUST | 0.00% | 47,530 | -1,252 | -2.57% | Mar 31, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 749 | - | - | Mar 31, 2024 |
Capricor Therapeutics's largest mutual fund holder by % of total assets is "VANGUARD VALLEY FORGE FUNDS", owning 16.00K shares, compromising 0.03% of its total assets.
Capricor Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 68 | 7.94% |
| 31 Mar, 24 | 63 | 57.50% |
| 31 Dec, 23 | 40 | 8.11% |
| 30 Sep, 23 | 37 | 2.78% |
| 30 Jun, 23 | 36 | 9.09% |
| 31 Mar, 23 | 33 | -13.16% |
| 31 Dec, 22 | 38 | 8.57% |
| 30 Sep, 22 | 35 | -5.41% |
| 30 Jun, 22 | 37 | 2.78% |
| 31 Mar, 22 | 36 | 20.00% |
| 31 Dec, 21 | 30 | -11.76% |
| 30 Sep, 21 | 34 | - |
| 30 Jun, 21 | 34 | -2.86% |
| 31 Mar, 21 | 35 | 16.67% |
| 31 Dec, 20 | 30 | -3.23% |
| 30 Sep, 20 | 31 | 3.33% |
| 30 Jun, 20 | 30 | 100.00% |
| 31 Mar, 20 | 15 | - |
| 31 Dec, 19 | 15 | - |
| 30 Sep, 19 | 15 | 36.36% |
| 30 Jun, 19 | 11 | - |
As of 30 Jun 24, 68 institutions are holding Capricor Therapeutics's shares, representing an increase of 7.94% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 6,426,234 | 33.35% |
| 31 Mar, 24 | 4,818,919 | 20.83% |
| 31 Dec, 23 | 3,988,123 | -27.56% |
| 30 Sep, 23 | 5,505,593 | 112.21% |
| 30 Jun, 23 | 2,594,364 | 7.93% |
| 31 Mar, 23 | 2,403,746 | -12.24% |
| 31 Dec, 22 | 2,739,017 | -1.91% |
| 30 Sep, 22 | 2,792,411 | 9.73% |
| 30 Jun, 22 | 2,544,875 | -1.81% |
| 31 Mar, 22 | 2,591,742 | 11.94% |
| 31 Dec, 21 | 2,315,365 | -6.86% |
| 30 Sep, 21 | 2,486,026 | -29.11% |
| 30 Jun, 21 | 3,506,925 | -18.80% |
| 31 Mar, 21 | 4,319,117 | 189.78% |
| 31 Dec, 20 | 1,490,483 | 21.32% |
| 30 Sep, 20 | 1,228,603 | 36.59% |
| 30 Jun, 20 | 899,450 | 80.50% |
| 31 Mar, 20 | 498,312 | 127.57% |
| 31 Dec, 19 | 218,973 | 76.84% |
| 30 Sep, 19 | 123,827 | 45.10% |
| 30 Jun, 19 | 85,342 | - |
Capricor Therapeutics (CAPR) has 6.43M shares outstanding as of 30 Jun 24, up 33.35% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 20.50% | 8.30% |
| 31 Mar, 24 | 15.72% | 6.59% |
| 31 Dec, 23 | 15.45% | 3.27% |
| 30 Sep, 23 | 21.73% | 20.58% |
| 30 Jun, 23 | 10.28% | 11.34% |
| 31 Mar, 23 | 9.52% | 8.04% |
| 31 Dec, 22 | 10.88% | 8.33% |
| 30 Sep, 22 | 11.43% | 10.44% |
| 30 Jun, 22 | 10.46% | 9.18% |
| 31 Mar, 22 | 10.67% | 10.61% |
| 31 Dec, 21 | 10.03% | 8.65% |
| 30 Sep, 21 | 10.76% | 4.57% |
| 30 Jun, 21 | 15.34% | 4.06% |
| 31 Mar, 21 | 19.43% | 36.31% |
| 31 Dec, 20 | 7.32% | 19.00% |
| 30 Sep, 20 | 6.20% | 17.56% |
| 30 Jun, 20 | 5.94% | 54.81% |
| 31 Mar, 20 | 3.29% | 157.25% |
| 31 Dec, 19 | 1.45% | 216.08% |
| 30 Sep, 19 | 0.82% | 257.27% |
| 30 Jun, 19 | 0.56% | - |
As of 30 Jun 24, Capricor Therapeutics is held by 20.50% institutional shareholders, representing a 8.30% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 42 | - |
| 31 Mar, 24 | 42 | 90.91% |
| 31 Dec, 23 | 22 | 83.33% |
| 30 Sep, 23 | 12 | -25.00% |
| 30 Jun, 23 | 16 | 14.29% |
| 31 Mar, 23 | 14 | -6.67% |
| 31 Dec, 22 | 15 | -6.25% |
| 30 Sep, 22 | 16 | 60.00% |
| 30 Jun, 22 | 10 | -44.44% |
| 31 Mar, 22 | 18 | 63.64% |
| 31 Dec, 21 | 11 | -15.38% |
| 30 Sep, 21 | 13 | -18.75% |
| 30 Jun, 21 | 16 | 6.67% |
| 31 Mar, 21 | 15 | -6.25% |
| 31 Dec, 20 | 16 | 33.33% |
| 30 Sep, 20 | 12 | -50.00% |
| 30 Jun, 20 | 24 | 300.00% |
| 31 Mar, 20 | 6 | -25.00% |
| 31 Dec, 19 | 8 | 33.33% |
| 30 Sep, 19 | 6 | -45.45% |
| 30 Jun, 19 | 11 | - |
42 institutional shareholders have increased their position in CAPR stock as of 30 Jun 24 compared to 42 in the previous quarter (a 0.00% increase).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 15 | 66.67% |
| 31 Mar, 24 | 9 | 12.50% |
| 31 Dec, 23 | 8 | -27.27% |
| 30 Sep, 23 | 11 | 57.14% |
| 30 Jun, 23 | 7 | 16.67% |
| 31 Mar, 23 | 6 | -45.45% |
| 31 Dec, 22 | 11 | 83.33% |
| 30 Sep, 22 | 6 | -33.33% |
| 30 Jun, 22 | 9 | 80.00% |
| 31 Mar, 22 | 5 | - |
| 31 Dec, 21 | 5 | -37.50% |
| 30 Sep, 21 | 8 | - |
| 30 Jun, 21 | 8 | -20.00% |
| 31 Mar, 21 | 10 | 150.00% |
| 31 Dec, 20 | 4 | -42.86% |
| 30 Sep, 20 | 7 | 600.00% |
| 30 Jun, 20 | 1 | - |
| 31 Mar, 20 | 1 | -66.67% |
| 31 Dec, 19 | 3 | -25.00% |
| 30 Sep, 19 | 4 | - |
| 30 Jun, 19 | - | - |
15 institutional shareholders have reduced their position in CAPR stock as of 30 Jun 24 compared to 9 in the previous quarter (a 66.67% increase).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 68 | 7.94% | 6,426,234 | 33.35% | 20.50% | 8.30% | 42 | - | 15 | 66.67% |
| 31 Mar, 24 | 63 | 57.50% | 4,818,919 | 20.83% | 15.72% | 6.59% | 42 | 90.91% | 9 | 12.50% |
| 31 Dec, 23 | 40 | 8.11% | 3,988,123 | -27.56% | 15.45% | 3.27% | 22 | 83.33% | 8 | -27.27% |
| 30 Sep, 23 | 37 | 2.78% | 5,505,593 | 112.21% | 21.73% | 20.58% | 12 | -25.00% | 11 | 57.14% |
| 30 Jun, 23 | 36 | 9.09% | 2,594,364 | 7.93% | 10.28% | 11.34% | 16 | 14.29% | 7 | 16.67% |
| 31 Mar, 23 | 33 | -13.16% | 2,403,746 | -12.24% | 9.52% | 8.04% | 14 | -6.67% | 6 | -45.45% |
| 31 Dec, 22 | 38 | 8.57% | 2,739,017 | -1.91% | 10.88% | 8.33% | 15 | -6.25% | 11 | 83.33% |
| 30 Sep, 22 | 35 | -5.41% | 2,792,411 | 9.73% | 11.43% | 10.44% | 16 | 60.00% | 6 | -33.33% |
| 30 Jun, 22 | 37 | 2.78% | 2,544,875 | -1.81% | 10.46% | 9.18% | 10 | -44.44% | 9 | 80.00% |
| 31 Mar, 22 | 36 | 20.00% | 2,591,742 | 11.94% | 10.67% | 10.61% | 18 | 63.64% | 5 | - |
| 31 Dec, 21 | 30 | -11.76% | 2,315,365 | -6.86% | 10.03% | 8.65% | 11 | -15.38% | 5 | -37.50% |
| 30 Sep, 21 | 34 | - | 2,486,026 | -29.11% | 10.76% | 4.57% | 13 | -18.75% | 8 | - |
| 30 Jun, 21 | 34 | -2.86% | 3,506,925 | -18.80% | 15.34% | 4.06% | 16 | 6.67% | 8 | -20.00% |
| 31 Mar, 21 | 35 | 16.67% | 4,319,117 | 189.78% | 19.43% | 36.31% | 15 | -6.25% | 10 | 150.00% |
| 31 Dec, 20 | 30 | -3.23% | 1,490,483 | 21.32% | 7.32% | 19.00% | 16 | 33.33% | 4 | -42.86% |
| 30 Sep, 20 | 31 | 3.33% | 1,228,603 | 36.59% | 6.20% | 17.56% | 12 | -50.00% | 7 | 600.00% |
| 30 Jun, 20 | 30 | 100.00% | 899,450 | 80.50% | 5.94% | 54.81% | 24 | 300.00% | 1 | - |
| 31 Mar, 20 | 15 | - | 498,312 | 127.57% | 3.29% | 157.25% | 6 | -25.00% | 1 | -66.67% |
| 31 Dec, 19 | 15 | - | 218,973 | 76.84% | 1.45% | 216.08% | 8 | 33.33% | 3 | -25.00% |
| 30 Sep, 19 | 15 | 36.36% | 123,827 | 45.10% | 0.82% | 257.27% | 6 | -45.45% | 4 | - |
| 30 Jun, 19 | 11 | - | 85,342 | - | 0.56% | - | 11 | - | - | - |
Capricor Therapeutics Insider Shareholders Trades
Open Market Insider Trades
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Capricor Therapeutics's stock was made by Musket David B on Aug 09 2024, selling 34,000 shares at $1.39 per share (valued at $47.26K).
Capricor Therapeutics Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 1 | 1 | 100.00% |
| Q2 2024 | 2 | 2 | 100.00% |
| Q1 2024 | 29 | - | - |
| Q4 2023 | 6 | - | - |
| Q3 2023 | 4 | 2 | 200.00% |
| Q2 2023 | 2 | 4 | 50.00% |
| Q1 2023 | 24 | 7 | 342.86% |
| Q4 2022 | 1 | 1 | 100.00% |
| Q2 2022 | 3 | 5 | 60.00% |
| Q1 2022 | 13 | 8 | 162.50% |
| Q4 2021 | 2 | 2 | 100.00% |
| Q3 2021 | 1 | - | - |
| Q1 2021 | 8 | - | - |
| Q3 2020 | 2 | 3 | 66.67% |
| Q2 2020 | 8 | - | - |
| Q1 2020 | 52 | 48 | 108.33% |
| Q4 2019 | 6 | - | - |
| Q3 2019 | 8 | - | - |
| Q3 2018 | 1 | - | - |
| Q1 2018 | 11 | - | - |
1 total buy trades, and 1 total sell trades (buy/sell ratio of 1.00%) were made by Capricor Therapeutics's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | - | - |
| Q2 2024 | - | - | - |
| Q1 2024 | - | - | - |
| Q4 2023 | 5 | - | - |
| Q3 2023 | - | - | - |
| Q2 2023 | - | 1 | - |
| Q1 2023 | - | 1 | - |
| Q4 2022 | - | - | - |
| Q2 2022 | 1 | 2 | 50.00% |
| Q1 2022 | - | - | - |
| Q4 2021 | - | - | - |
| Q3 2021 | - | - | - |
| Q1 2021 | - | - | - |
| Q3 2020 | - | - | - |
| Q2 2020 | - | - | - |
| Q1 2020 | - | - | - |
| Q4 2019 | - | - | - |
| Q3 2019 | - | - | - |
| Q3 2018 | - | - | - |
| Q1 2018 | - | - | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Capricor Therapeutics's stocks.
Capricor Therapeutics Peer Ownership
| Ticker | Company |
|---|---|
| SLNO | Soleno Therapeutics, Inc. |
| ANAB | AnaptysBio, Inc. |
| IDYA | IDEAYA Biosciences, Inc. |
| PULM | Pulmatrix, Inc. |
| NXTC | NextCure, Inc. |
| MGTX | MeiraGTx Holdings plc |
| BPTH | Bio-Path Holdings, Inc. |
| PHIO | Phio Pharmaceuticals Corp. |
| DFFN | CervoMed Inc. |
| AKTX | Akari Therapeutics, Plc |
| KROS | Keros Therapeutics, Inc. |
| MBRX | Moleculin Biotech, Inc. |
| ONTX | Traws Pharma, Inc. |
| UNCY | Unicycive Therapeutics, Inc. |
| FIXX | Q32 Bio Inc. |
| CDTX | Cidara Therapeutics, Inc. |
| CBIO | Gyre Therapeutics, Inc. |
CAPR Ownership FAQ
Who Owns Capricor Therapeutics?
Capricor Therapeutics is owned by institutional shareholders (20.50%), insiders (23.38%), and public (56.13%). The largest institutional shareholder of Capricor Therapeutics is BLACKROCK INC. (5.19% of total shares) and the top mutual fund owner is VANGUARD VALLEY FORGE FUNDS (0.03% of total shares).
Who are the major institutional shareholders of Capricor Therapeutics?
Capricor Therapeutics's major institutional shareholders are BLACKROCK INC., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, MILLENNIUM MANAGEMENT LLC, and STATE STREET CORP. The top five shareholders own together 14.99% of the company's share outstanding.
How many Capricor Therapeutics shareholders are there?
As of Jun 2024, there are 68 institutional shareholders of Capricor Therapeutics.
What percentage of Capricor Therapeutics is owned by BLACKROCK INC?
BLACKROCK INC owns 1.63M shares of Capricor Therapeutics, representing 5.19% of the company's total shares outstanding, valued at $7.77M (as of Jun 2024).
What percentage of Capricor Therapeutics is owned by VANGUARD GROUP INC?
As of Jun 2024, VANGUARD GROUP INC holds 1.55M shares of Capricor Therapeutics (CAPR), compromising 4.94% of the company, valued at $7.39M.
What percentage of Capricor Therapeutics is owned by GEODE CAPITAL MANAGEMENT, LLC?
GEODE CAPITAL MANAGEMENT, LLC is the third largest holder of Capricor Therapeutics. The company owns 641.57K of the company's shares outstanding (worth $3.06M).